MADISON (WKOW) — UW Health treated the first patient nationwide with investigational cell therapy in October. It’s a new treatment designed to combat a common, yet debilitating heart disease.
According to a news release from UW Health spokesperson Emily Kumlien, investigational therapy is designed to treat chronic myocardial ischemia (CMI). CMI stems from reduced blood flow to the heart, often caused by blockages in coronary arteries.
The nature of CMI makes it difficult to treat with traditional medicine, but also does not leave patients in a position to get a stent or bypass surgery. According to Dr. Amish Raval, who